drugset / Trial / NCT04987281

Robotic Bronchoscopy With Cone CT and Indocyanine Green to Aid Removal of Lung Lesions in Patients With Stage I Non-small Cell Lung Cancer or Lung Metastases, REPLACING Study

NCT04987281

Phase 2 Withdrawn M.D. Anderson Cancer Center
NaSingle-groupOpen-labelDevice feasibility

Summary

This phase II trial studies the use of Ion robotic bronchoscope with a mobile computed tomography (CT) scanner to biopsy tumors and inject a fluorescent dye called indocyanine green to mark the tumor during surgery in patients with stage I non-small cell lung cancer or cancer that has spread to the lung (lung metastases). Sometimes small tumors or those that are not on the surface of the lung can be challenging to remove without making larger incisions. Injecting the dye, may help doctors see the tumor more easily, which may allow for smaller incisions and by being able to see the tumor, doctors may be better able to decide where to make the incisions in order to get all of the tumor out.

Timeline

Start
2022-01-26
Primary completion
2023-12-27
Completion
2023-12-27

Drugs

EvaluationDrugModalityDoseRoute
Background Indocyanine Green Diagnostic / imaging agent